Assets
(3 total)
3Total Assets
0Approved
1Phase 3 / Filed
2Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | Airway epithelial regeneration (autologous basal cells)Cell therapy | Chronic Obstructive Pulmonary Disease | |
| Phase 1 | Renal progenitor cell therapyCell therapy | Type 2 DiabetesChronic Kidney Disease | |
| Phase 1 | Airway basal layer stem cellsCell therapy | Chronic Obstructive Pulmonary Disease |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.